Demonstration of novel innate immune cells in psoriasis
© Mak et al; licensee BioMed Central Ltd. 2010
Published: 25 November 2010
Psoriasis is a common chronic inflammatory skin disorder affecting ~2% of the population worldwide. Both the adaptive and innate immune systems are important in driving the inflammation in genetically susceptible individuals. HLA-Cw6 located within the PSORS1 region on chromosome 6 is the most important psoriasis genetic marker. Correlations of HLA-C expression with different disease incidence and progression are described in the context of HLA-C’s interaction with killer-like immunoglobulin receptors (KIR) expressed on innate immune effector cells; natural killer (NK) and natural killer T (NKT) cells.
We aimed to study the expression of KIR2DL1, the natural receptor for HLA-Cw6, in blood and skin of psoriasis patients and normal controls.
Patients and methods
Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples of psoriasis patients (n=46) and normal controls (n=10). The expression of skin homing markers and the cytokine production profile of peripheral KIR2DL1+ lymphocytes were further studied by flow cytometry analysis. Demonstration of KIR2DL1 cells in skin was performed with immunofluorescence (IF) staining and confocal imaging on frozen skin sections (n=3) and epidermal sheets (n=3).
The majority of blood derived KIR2DL1+ lymphocytes are NK cells expressing CD56 with a small percentage of NKT cells expressing both CD56 and CD3. Peripheral KIR2DL1+ lymphocytes express a range of skin homing markers including CLA, CCR4, CCR6 and CCR10, indicating their capacity to migrate from the periphery to skin. Furthermore, these cells are capable of producing different psoriasis relevant cytokines such as TNFα and IFNγ. IF staining demonstrated CD56+/CD3+ KIR2DL1+ cells in epidermis and dermal-epidermal junctions in both normal and psoriasis skin.
This is the first in situ demonstration of KIR2DL1+ cells in psoriasis skin. Their interaction with HLA-Cw6 expressing cells might affect the cytokine milieu in psoriasis and constitute a novel innate immune pathway important in psoriasis pathogenesis.
This article is published under license to BioMed Central Ltd.